Cserhalmi-Friedman P B, Milstone L M, Christiano A M
Departments of Dermatology and Genetics and Development, Columbia University, College of Physicians & Surgeons, 630 W 168th Street VC-1526, New York, NY 10032, USA.
Br J Dermatol. 2001 Apr;144(4):726-30. doi: 10.1046/j.1365-2133.2001.04126.x.
Autosomal recessive lamellar ichthyosis (ARLI) is a clinically and genetically heterogeneous disorder. In many cases, mutations in the transglutaminase 1 gene (TGM1) have been identified, however, other clinically indistinguishable cases have been linked to chromosomes 2, 3 and 19. Previous studies have failed to establish any correlation between clinical characteristics and genetic mutations.
To investigate the molecular basis of ARLI in 10 patients with the typical clinical presentation of the disorder.
We performed polymerase chain reaction and direct sequencing-based mutation screening in all of these patients, and TGM1 immunofluorescence microscopy and in vitro enzyme activity assays in selected patients.
Mutation screening revealed 14 mutations, four of which have been previously described. While immunofluorescence microscopy was negative in patients with non-sense mutations or out-of-frame insertions or deletions, the results were variable in cases with mis-sense mutations and in cases with no mutations in the TGM1 gene. In vitro enzyme activity assays gave results consistent with the mutation data.
Our findings support the importance of mutation screening in the evaluation of ARLI.
常染色体隐性层状鱼鳞病(ARLI)是一种临床和遗传上的异质性疾病。在许多病例中,已鉴定出转谷氨酰胺酶1基因(TGM1)的突变,然而,其他临床无法区分的病例与2号、3号和19号染色体有关。先前的研究未能确立临床特征与基因突变之间的任何关联。
研究10例具有该疾病典型临床表现的ARLI患者的分子基础。
我们对所有这些患者进行了聚合酶链反应和基于直接测序的突变筛查,并对部分患者进行了TGM1免疫荧光显微镜检查和体外酶活性测定。
突变筛查发现了14种突变,其中4种先前已有描述。无义突变、框外插入或缺失的患者免疫荧光显微镜检查结果为阴性,而错义突变患者以及TGM1基因无突变的患者结果则各不相同。体外酶活性测定结果与突变数据一致。
我们的研究结果支持了突变筛查在ARLI评估中的重要性。